Athlete's Foot: A Common Fungal Infection in Athletes and Beyond. The Use of Terbinafine in Treating Tinea Pedis and Onychomycosis
DOI:
https://doi.org/10.12775/QS.2024.34.56195Keywords
athlete's foot, tinea pedis, onychomycosis, terbinafineAbstract
Introduction: Tinea pedis is one of the most common skin conditions that often affects athletes, which is referred to by another name for the condition - Athlete's foot. It is a fungal infection that manifests itself with symptoms such as itching, redness, exfoliating skin and cracking of the epidermis. The foot skin infection can spread to the nails, so in this review we will discuss both conditions. Terbinafine is an allylamine derivative with antifungal activity. It can be applied both superficially and orally. It is used to treat fungal infections, including tinea pedis and onychomycosis.
Aim of the study: The aim of this publication is to review the available literature to answer the question of whether terbinafine is an effective treatment for athlete's foot and onychomycosis.
Methods: Review of specialised literature in the field of dermatology and PubMed and Google Scholar databases by searching with keywords such as athlete’s foot, tinea pedis, onychomycosis, terbinafine.
Conclusion: Tinea pedis and often associated onychomycosis are a medical problem affecting a wide social group. Topical or systemic drugs can be used to treat the aforementioned conditions. Terbinafine, which is a drug belonging to the allylamines, is effective in the treatment of tinea pedis and onychomycosis and has a high safety profile. There are terbinafine products on the market in various forms, e.g. emulsions, creams, film-forming solution, pills, so it is therefore easy to choose a suitable and convenient treatment. The use of lasers such as CO2 fractional laser or Nd:YAG laser seems to be beneficial in the complementary treatment of onychomycosis with terbinafine.
References
Nowicki, Roman J.; Romaszkiewicz, Alicja. 2022 „Infekcje Dermatofitowe” In Współczesna dermatologia tom 1, edited by Rudnicka, Lidia; Olszewska, Małgorzata; Rakowska, Adriana; Sar-Pomian, Marta, Warszawa: PZWL Wydawnictwo Lekarskie, 2022, ISBN 978-83-01-22653-4, doi: https://doi.org/10.53271/2022.033
Hryncewicz- Gwóźdź, Anita. 2021„ Grzybice Powierzchowne Skóry i Paznokci” In W gabinecie lekarza specjalisty. Dermatologia. Dylematy lekarza praktyka w wybranych dermatozach edited by Maj, Joanan. PZWL Wydawnictwo Lekarskie, 2021, ISBN 978-83-200-6285-4
Sasagawa, Yukio. “Internal environment of footwear is a risk factor for tinea pedis.” The Journal of dermatology vol. 46,11 (2019): 940-946. doi:10.1111/1346-8138.15060
Kermani, Firoozeh et al. “Tinea Gladiatorum and Dermatophyte Contamination Among Wrestlers and in Wrestling Halls: A Systematic Review and Meta-analysis.” Current microbiology vol. 77,4 (2020): 602-611. doi:10.1007/s00284-019-01816-3
Collins, Cathal James, and Brian O'Connell. “Infectious disease outbreaks in competitive sports, 2005-2010.” Journal of athletic training vol. 47,5 (2012): 516-8. doi:10.4085/1062-6050-47.5.02
Olszanecki, Rafał. 2017.“Leki używane w zwalczaniu infekcji. Leki przeciwgrzybicze” In Farmakologia edited by Korbut, Ryszard PZWL Wydawnictwo Lekarskie, 2017, pp 300-303 ISBN 978-83-200-5450-7
Ranjan, Eeshaan et al. “Fractional CO2 laser with topical 1% terbinafine cream versus oral itraconazole in the management of onychomycosis: A randomized controlled trial.” Indian journal of dermatology, venereology and leprology vol. 89,1 (2023): 47-53. doi:10.25259/IJDVL_98_2021
El-Tatawy, Rania A et al. “A comparative clinical and mycological study of Nd-YAG laser versus topical terbinafine in the treatment of onychomycosis.” The Journal of dermatological treatment vol. 26,5 (2015): 461-4. doi:10.3109/09546634.2014.998607
Xu, Yang et al. “Combined oral terbinafine and long-pulsed 1,064-nm Nd: YAG laser treatment is more effective for onychomycosis than either treatment alone.” Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] vol. 40,11 (2014): 1201-7. doi:10.1097/DSS.0000000000000157
Shi, Jian et al. “The efficacy of fractional carbon dioxide (CO2) laser combined with terbinafine hydrochloride 1% cream for the treatment of onychomycosis.” Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology vol. 19,6 (2017): 353-359. doi:10.1080/14764172.2017.1334925
Nawrot, Urszula “Terbinafine and its role in the therapy of fungal infection” Forum Zakażeń 2020;11(1):39–47. DOI: doi:10.15374/FZ2019064
White, J E et al. “Successful 2-week treatment with terbinafine (Lamisil) for moccasin tinea pedis and tinea manuum.” The British journal of dermatology vol. 125,3 (1991): 260-2. doi:10.1111/j.1365-2133.1991.tb14752.x
Kikuchi, Izumi et al. “Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis.” Mycoses vol. 51,1 (2008): 7-13. doi:10.1111/j.1439-0507.2007.01438.x
Auvinen, T et al. “Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.” The British journal of dermatology vol. 173,4 (2015): 940-8. doi:10.1111/bjd.13934
Shi, Tian-Wei et al. “Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.” Mycoses vol. 57,9 (2014): 560-4. doi:10.1111/myc.12198
Sánchez-Schmidt, Julia M et al. “Estudio de satisfacción con el tratamiento de las micosis en extremidades con terbinafina (SETTA)” [Study on patient satisfaction with the treatment of mycosis on the extremities with terbinafine (SETTA)]. Actas dermo-sifiliograficas vol. 96,5 (2005): 285-90. doi:10.1016/s0001-7310(05)75055-9
Cañete-Gibas, Connie F et al. “Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America.” Journal of clinical microbiology vol. 61,8 (2023): e0056223. doi:10.1128/jcm.00562-23
Singh, Sanjay, and Prakriti Shukla. “End of the road for terbinafine? Results of a pragmatic prospective cohort study of 500 patients.” Indian journal of dermatology, venereology and leprology vol. 84,5 (2018): 554-557. doi:10.4103/ijdvl.IJDVL_526_17
Rotta, Inajara et al. “Efficacy of topical antifungal drugs in different dermatomycoses: a systematic review with meta-analysis.” Revista da Associacao Medica Brasileira (1992) vol. 58,3 (2012): 308-18.
Evans, E G et al. “Comparison of terbinafine and clotrimazole in treating tinea pedis.” BMJ (Clinical research ed.) vol. 307,6905 (1993): 645-7. doi:10.1136/bmj.307.6905.645
Patel, A et al. “Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole.” The Australasian journal of dermatology vol. 40,4 (1999): 197-200. doi:10.1046/j.1440-0960.1999.00360.x
James, Ian G et al. “Short-duration topical treatment of tinea pedis using terbinafine emulsion gel: results of a dose-ranging clinical trial.” The Journal of dermatological treatment vol. 18,3 (2007): 163-8. doi:10.1080/09546630701247971
Korting, H C et al. “One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group.” Medical mycology vol. 39,4 (2001): 335-40. doi:10.1080/mmy.39.4.335.340
Brown, Marc et al. “Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.” American journal of clinical dermatology vol. 14,5 (2013): 413-9. doi:10.1007/s40257-013-0031-y
Korting, Hans Christian et al. “Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.” American journal of clinical dermatology vol. 8,6 (2007): 357-64. doi:10.2165/00128071-200708060-00005
de Chauvin, Martine Feuilhade et al. “Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial.” Mycoses vol. 51,1 (2008): 1-6. doi:10.1111/j.1439-0507.2007.01429.x
Li, Ruo Yu et al. “Efficacy and safety of 1 % terbinafine film-forming solution in Chinese patients with tinea pedis: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.” Clinical drug investigation vol. 34,3 (2014): 223-30. doi:10.1007/s40261-014-0171-8
Ortonne, J P et al. “Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.” Journal of the European Academy of Dermatology and Venereology : JEADV vol. 20,10 (2006): 1307-13. doi:10.1111/j.1468-3083.2006.01807.x
Yadav, Pravesh et al. “Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.” Indian journal of dermatology, venereology and leprology vol. 81,4 (2015): 363-9. doi:10.4103/0378-6323.158634
Tavakkol, Amir et al. “Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis.” Antimicrobial agents and chemotherapy vol. 68,10 (2024): e0068224. doi:10.1128/aac.00682-24
Gupta, Aditya K et al. “Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.” Journal of the American Academy of Dermatology vol. 85,1 (2021): 95-104. doi:10.1016/j.jaad.2020.06.055
Blume-Peytavi, Ulrike et al. “A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.” Mycoses vol. 65,4 (2022): 392-401. doi:10.1111/myc.13392
Gupta, A K et al. “Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis.” The British journal of dermatology vol. 182,2 (2020): 287-299. doi:10.1111/bjd.18155
Fávero, Maria L D et al. “Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis.” The Journal of dermatological treatment vol. 33,1 (2022): 121-130. doi:10.1080/09546634.2020.1729336
Fujiwara, Yuko et al. “Beneficial effects of foot care nursing for people with diabetes mellitus: an uncontrolled before and after intervention study.” Journal of advanced nursing vol. 67,9 (2011): 1952-62. doi:10.1111/j.1365-2648.2011.05640.x
Ogawa, Takasuke et al. “Risk factors for the development of tinea pedis and onychomycosis: Real-world evidence from a single-podiatry center, large-scale database in Japan.” The Journal of dermatology vol. 51,1 (2024): 30-39. doi:10.1111/1346-8138.16991
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anita Ptak, Michał Szyc
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 25
Number of citations: 0